Atea Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AVIR Nasdaq 2834 ateapharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 13th, 2025 12:00 pm
Atea Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 8th, 2025 12:00 pm
US Penny Stocks To Watch In December 2024 - Dec 24th, 2024 5:07 pm
Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships - Dec 16th, 2024 10:00 am
Atea Pharmaceuticals announces results from Phase 2 regimen of bemnifosbuvir - Dec 5th, 2024 12:06 pm
After Failed COVID-19 Drug Trial, Atea Pharmaceuticals Touts Encouraging Data From Mid-Stage Hepatitis C Study - Dec 4th, 2024 8:14 pm
Atea Pharmaceuticals Announces Positive Results from Phase 2 Study of Bemnifosbuvir and Ruzasvir Regimen for Treatment of Hepatitis C Virus (HCV) - Dec 4th, 2024 12:00 pm
Atea plans Phase 3 study for hepatitis C drug after mid-stage results - Dec 4th, 2024 11:09 am
Atea Pharmaceuticals to Present and Provide a Business Update at the 7th Annual Evercore HealthCONx Conference - Nov 26th, 2024 12:00 pm
Promising US Penny Stocks To Watch In November 2024 - Nov 25th, 2024 1:11 pm
Is Atea Pharmaceuticals (AVIR) Stock Outpacing Its Medical Peers This Year? - Nov 22nd, 2024 2:40 pm
Atea Pharmaceuticals Presents Multiple New Datasets Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024 - Nov 15th, 2024 4:00 pm
Atea Pharmaceuticals Inc (AVIR) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ... - Nov 12th, 2024 1:01 am
Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - Nov 7th, 2024 9:05 pm
Atea Pharmaceuticals to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024 - Oct 31st, 2024 11:00 am
Atea Pharmaceuticals to Present New Data Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024 - Oct 30th, 2024 11:00 am
Atea Pharmaceuticals Leads The Charge In US Penny Stocks Spotlight - Oct 21st, 2024 8:31 pm
Are Medical Stocks Lagging Atea Pharmaceuticals (AVIR) This Year? - Oct 16th, 2024 1:40 pm
Atea Pharmaceuticals Inc (AVIR) Q2 2024 Earnings Call Highlights: Strong Financial Position and ... - Oct 9th, 2024 9:19 pm
Atea Pharmaceuticals (AVIR) Loses -8.01% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Oct 4th, 2024 1:35 pm